The Shenzhen-based nonprofit research institute will be equipped with NGS instruments developed by BGI and will include a biorepository and bioinformatics center.
Researchers used metagenomic sequencing to profile gut microbial genes in pigs from three countries, representing hundreds of animals across 17 breeds.
The startup, which was founded in 2015 by former BGI employees, is developing next-generation sequencing tests for cancer applications.
Last year, Radboud University Medical Centre's genetics lab conducted about 6,000 diagnostic exome tests and ran 2,000 nex-gen sequencing-based BRCA1/2 hereditary cancer assays.
BGI will work with researchers in Australia on agricultural and human health projects, and will seek new partnerships across the region.
BGI has signed an agreement to offer NRGene's bioinformatics tools as part of its agricultural genomic analysis service to customers in Asia.
Genomed, based in Warsaw, offers sequencing-based diagnostic and research services and brought BGI's noninvasive prenatal NIFTY test in house last year.
The two organizations signed a memorandum of understanding this week, following the opening of the BGI-VPC Joint Research Laboratory in 2014.
Mao Mao joined BGI Genomics in February from WuXi AppTec, where he was responsible for in vitro diagnostics product development and clinical lab services.
BGI will distribute Clearbridge's ClearCell FX1 CTC isolation technology in China and work to extend the system into new clinical and research applications.
The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.